CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+5.12%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$5.78B
AUM Growth
+$56.1M
(+0.98%)
Cap. Flow
-$211M
Cap. Flow
% of AUM
-3.66%
Top 10 Holdings %
Top 10 Hldgs %
16.17%
Holding
798
New
72
Increased
310
Reduced
286
Closed
45
Top Buys
| 1 |
Amgen
AMGN
|
+$28M |
| 2 |
Meta Platforms (Facebook)
META
|
+$25.9M |
| 3 |
Southwest Airlines
LUV
|
+$18.5M |
| 4 |
Travelers Companies
TRV
|
+$17.6M |
| 5 |
Cigna
CI
|
+$16.9M |
Top Sells
| 1 |
Biogen
BIIB
|
+$75.9M |
| 2 |
Johnson & Johnson
JNJ
|
+$27.9M |
| 3 |
Gilead Sciences
GILD
|
+$25M |
| 4 |
Neurocrine Biosciences
NBIX
|
+$22.7M |
| 5 |
Amazon
AMZN
|
+$21.4M |
Sector Composition
| 1 | Healthcare | 22.62% |
| 2 | Technology | 14.66% |
| 3 | Financials | 14.55% |
| 4 | Consumer Discretionary | 9.89% |
| 5 | Communication Services | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Mettler-Toledo International
MTD
$27.1B
| $2.48M | 0.04% |
4,009
-128
| -3% | -$79.3K |
|
402
M&T Bank
MTB
$31.1B
| $2.48M | 0.04% |
14,528
-739
| -5% | -$126K |
|
|
ZGNX
403
DELISTED
Zogenix, Inc.
ZGNX
| $2.48M | 0.04% |
62,000
-105,000
| -63% | -$4.21M |
|
|
AKRX
404
DELISTED
Akorn, Inc.
AKRX
| $2.47M | 0.04% |
76,686
-40,431
| -35% | -$1.3M |
|
|
MDCO
405
DELISTED
Medicines Co
MDCO
| $2.41M | 0.04% |
88,000
-14,000
| -14% | -$383K |
|
406
Hewlett Packard
HPE
$31.5B
| $2.38M | 0.04% |
165,978
+4,267
| +3% | +$61.3K |
|
407
Zebra Technologies
ZBRA
$16B
| $2.38M | 0.04% |
22,936
-321
| -1% | -$33.3K |
|
|
LUMO
408
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $2.38M | 0.04% |
32,556
-3,888
| -11% | -$284K |
|
409
Citizens Financial Group
CFG
$22.3B
| $2.38M | 0.04% |
56,567
+8,051
| +17% | +$338K |
|
410
Cadence Design Systems
CDNS
$98.6B
| $2.37M | 0.04% |
56,736
-6,009
| -10% | -$251K |
|
411
Waters Corp
WAT
$18.4B
| $2.36M | 0.04% |
12,222
-873
| -7% | -$169K |
|
412
Consolidated Edison
ED
$34.9B
| $2.35M | 0.04% |
27,620
+2,687
| +11% | +$228K |
|
413
Sarepta Therapeutics
SRPT
$1.85B
| $2.34M | 0.04% |
+42,000
| New | +$2.34M |
|
414
Huntington Bancshares
HBAN
$25.9B
| $2.33M | 0.04% |
160,185
+28,487
| +22% | +$415K |
|
415
Acadia Pharmaceuticals
ACAD
$4.28B
| $2.32M | 0.04% |
77,000
| – | – |
|
|
SRRA
416
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $2.24M | 0.04% |
+15,000
| New | +$2.24M |
|
417
CMS Energy
CMS
$21.2B
| $2.23M | 0.04% |
47,033
+741
| +2% | +$35.1K |
|
418
TG Therapeutics
TGTX
$5.14B
| $2.21M | 0.04% |
270,000
+50,000
| +23% | +$410K |
|
419
Eversource Energy
ES
$23.3B
| $2.2M | 0.04% |
34,786
+2,329
| +7% | +$147K |
|
420
McKesson
MCK
$87.8B
| $2.16M | 0.04% |
13,876
-18,106
| -57% | -$2.82M |
|
|
BHVN
421
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.16M | 0.04% |
+80,000
| New | +$2.16M |
|
422
Annaly Capital Management
NLY
$14.2B
| $2.16M | 0.04% |
45,328
+2,099
| +5% | +$99.8K |
|
423
Pacira BioSciences
PCRX
$1.2B
| $2.15M | 0.04% |
47,000
-6,000
| -11% | -$274K |
|
|
AGEN
424
Agenus
AGEN
$136M
| $2.14M | 0.04% |
33,372
+1,900
| +6% | +$122K |
|
425
MGM Resorts International
MGM
$9.85B
| $2.12M | 0.04% |
63,559
+2,654
| +4% | +$88.6K |
|